Advertisement

Pharmaceutical Chemistry Journal

, Volume 53, Issue 10, pp 942–946 | Cite as

Cytoprotection Activity Evaluation of (E)-3-(3,4-Dichlorophenyl)-1-(3,4-Dihydroxyphenyl)- Prop-2-En-1-One as a New Antioxidant Against H2O2-Induced Oxidative Damage in PC12 Cells

  • Jing Meng
  • Shi-jian Wang
  • Yi LiuEmail author
Article
  • 3 Downloads

Scavenging reactive oxygen species (ROS) by antioxidants is an important therapy to neurodegenerative diseases. In this work, a new chalcone compound (E)-3-(3,4 -dichlorophenyl)-1-(3,4-dihydroxyphenyl)-prop-2-en-1-one (A1) with potent antioxidant activity in PC12 cells was found. The MTT assay showed that A1 at 10 μM had no apparent cytotoxicity in PC12 cells. DPPH assay exhibited A1 could scavenge ROS directly. Treatment with A1 could elevate the population of viable cells in a dose-dependent manner. Furthermore, A1 protected PC12 cells against H2O2-induced apoptosis. At the molecular level, A1 conferred cytoprotection against oxidative damage in PC12 cells via up-regulation of the expression of HO-1 and GCLC proteins. These findings suggest compound A1 to be a promising antioxidant for the treatment oxidative stress-related diseases.

Keywords

reactive oxygen species chalcones antioxidants oxidative stress Nfr2 

Notes

Acknowledgments

The work was supported by the Science and Technology Plan of Jiaojiang District, Taizhou City (No. 162039).

References

  1. 1.
    P. C. Trippier, L. K. Jansen, D. D. Hawker, et al., J. Med. Chem., 56, 3121 – 3147 (2013).CrossRefGoogle Scholar
  2. 2.
    S. Magesh, Y. Chen, and L. Hu., Med. Res. Rev., 32, 687 – 726 (2012).CrossRefGoogle Scholar
  3. 3.
    L. Huang, J. Wang, L. Chen, et al., Eur. J. Med. Chem., 143, 1165 – 1173 (2018).CrossRefGoogle Scholar
  4. 4.
    J. Wu, J. Ren, S. Yao, et al., Bioorg. Med. Chem. Lett., 27, 1616 – 1619 (2017).CrossRefGoogle Scholar
  5. 5.
    Y. Liu, K. Ai, X. Ji, et al., J. Am. Chem. Soc., 139, 856 – 862 (2017).CrossRefGoogle Scholar
  6. 6.
    A. Y. Shih, P. Li, and T. H. Murphy., J. Neurosci., 25, 10321 –10335 (2015).Google Scholar
  7. 7.
    J. Teixeira, F. Cagide, S. Benfeito, et al., J. Med. Chem., 60, 7084 – 7098 (2017).CrossRefGoogle Scholar
  8. 8.
    Z. Guo, Acta Pharm. Sin. B., 7, 119 – 136 (2017).CrossRefGoogle Scholar
  9. 9.
    J. R. Dimmock, W. D. Elias, M. A. Beazely, et al., Curr. Med. Chem., 6, 1125 – 1149 (1999).PubMedGoogle Scholar
  10. 10.
    V. Kumar, S. Kumar, M. Hassan, et al., J. Med. Chem., 54, 4147 – 4159 (2011).CrossRefGoogle Scholar
  11. 11.
    A. Benayahoum, H. A. Guebailia, and O. Houache., J. Mol. Model., 19, 2285 – 2298 (2013).Google Scholar
  12. 12.
    X. Ning, Y. Guo, Y. X. Wang, et al., J. Med. Chem., 57, 4302 – 4312 (2014).CrossRefGoogle Scholar
  13. 13.
    K. A. Jung and M. K. Kwak, Molecules, 15, 7266 – 7291 (2010).CrossRefGoogle Scholar
  14. 14.
    J. Wu, J. Ling, X. Wang, et al., J. Med. Chem., 55, 7173 – 7181(2012).CrossRefGoogle Scholar
  15. 15.
    J. Yao, B. Zhang, C. Ge, et al., J. Agric. Food Chem., 63, 1521 – 1531 (2015).CrossRefGoogle Scholar
  16. 16.
    K. H. Jeon, E. Lee, K. Y. Jun, et al., Eur. J. Med. Chem., 121, 433 – 444 (2016).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2020

Authors and Affiliations

  1. 1.Department of PharmacyShanxian Central HospitalHezeChina
  2. 2.Municipal Hospital Affiliated to Medical School of Taizhou UniversityTaizhouChina
  3. 3.Department of GastroenterologyShanxian Central HospitalHezeChina

Personalised recommendations